Seasonal Influenza

Infectious Disease·MeSH: Influenza, Human

4 drugs in development·3 companies·3 clinical trials

Drug Pipeline by Phase

Phase 3(2)

Drug	Company
Licensed Quadrivalent Inactivated Seasonal Influenza Vaccine	Moderna, Inc. (MRNA)
mRNA-1010	Moderna, Inc. (MRNA)

Phase 2(1)

Drug	Company
tivoxavir marboxil	TRAWS PHARMA, INC. (ONTX)

Phase 1(1)

Drug	Company
LUNAR-FLU (seasonal influenza candidate)	Arcturus Therapeutics Holdings Inc. (ARCT)

BioSniper tracks 4 drugs in development for Seasonal Influenza across 3 companies.

There are 3 clinical trials targeting Seasonal Influenza tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.